Hypertension, or high blood pressure, remains a significant global health concern, affecting over 1.28 billion people worldwide and contributing to the leading causes of cardiovascular disease, stroke, and kidney failure. Despite decades of research, challenges persist in developing more effective, personalized medications for managing hypertension, especially for those with resistant or secondary forms of the condition. However, a new frontier is emerging: artificial intelligence (AI). Leveraging the power of AI in drug discovery is revolutionizing the speed, efficiency, and precision with which new hypertension treatments are being developed. This article explores how AI is transforming hypertension drug discovery, the technologies driving this innovation, and the potential it holds for advancing cardiovascular medicine.
